Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 1,000,000 shares, a growth of 80.6% from the May 15th total of 553,600 shares. Based on an average daily trading volume, of 1,390,000 shares, […]
Wall Street analysts expect that Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) will announce earnings of ($0.06) per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Artelo Biosciences’ earnings. Artelo Biosciences posted earnings per share of ($0.11) during the same quarter last year, which would indicate a positive […]
Wall Street analysts forecast that Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) will report earnings per share of ($0.06) for the current quarter, according to Zacks. Zero analysts have made estimates for Artelo Biosciences’ earnings. Artelo Biosciences reported earnings per share of ($0.11) in the same quarter last year, which suggests a positive year over […]